Jacquie Ross | VP, IR |
Daniel O'Day | Chairman & CEO |
Johanna Mercier | Chief Commercial Officer |
Merdad Parsey | Chief Medical Officer |
Andrew Dickinson | EVP & CFO |
Christi Shaw | CEO, Kite |
Michael Yee | Jefferies |
Brian Abrahams | RBC Capital Markets |
Geoffrey Meacham | Bank of America Merrill Lynch |
Robyn Karnauskas | Truist Securities |
Umer Raffat | Evercore ISI |
Colin Bristow | UBS |
Tyler Van Buren | Cowen and Company |
Gavin Scott | JPMorgan Chase & Co. |
Guyn Kim | Piper Sandler & Co. |
Evan Seigerman | BMO Capital Markets |
Mohit Bansal | Wells Fargo Securities |
Simon Baker | Redburn |
Thank you for standing by and welcome to the Gilead Sciences First Quarter 2022 Earnings Conference Call. [Operator Instructions]. I will now like to hand the call over to your host for today's program, Jacquie Ross, Vice President, Investor Relations. Please go ahead.
Thank you, Jonathan, and good afternoon, everyone.